Literature DB >> 2910126

Roux-Y gastrectomy for chronic gastric atony.

L Karlstrom1, K A Kelly.   

Abstract

The aim of this study was to determine the clinical outcome after Roux-Y gastrectomy for chronic gastric atony. Forty patients (11 men, 29 women; age 47 +/- 12 years) presented with severe chronic gastric atony: 32 patients had postvagotomy atony, 6 had idiopathic atony, and 2 had diabetic gastroparesis. The patients underwent either extensive subtotal or near-total gastrectomy and Roux-Y gastrojejunostomy. No early postoperative mortality occurred. Among the 39 patients followed for a mean of 32 months, 31 patients (79 percent) had fewer symptoms postoperatively than preoperatively, with 26 patients (66 percent) improving at least one Visick grade postoperatively and 22 patients (56 percent) going from grades III and IV preoperatively to grades I and II postoperatively. In contrast, 13 patients (33 percent) did not improve after operation. We concluded that extensive subtotal Roux-Y gastrectomy and near-total Roux-Y gastrectomy were safe procedures that led to improvement in two-thirds of the patients with chronic gastric atony; however, one-third of patients did not have improvement.

Entities:  

Mesh:

Year:  1989        PMID: 2910126     DOI: 10.1016/0002-9610(89)90418-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  18 in total

1.  Gastrointestinal motility of patients with Roux-en-Y reconstruction.

Authors:  J C Coelho; L Clemente; J E Matias; A C Campos; J C Wiederkehr
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

Review 2.  Endoscopic and Surgical Treatments for Gastroparesis: What to Do and Whom to Treat?

Authors:  Roman V Petrov; Charles T Bakhos; Abbas E Abbas; Zubair Malik; Henry P Parkman
Journal:  Gastroenterol Clin North Am       Date:  2020-06-20       Impact factor: 3.806

3.  Laparoscopy-assisted uncut Roux-en-Y operation after distal gastrectomy for gastric cancer.

Authors:  Ichiro Uyama; Yoichi Sakurai; Yoshiyuki Komori; Yasuko Nakamura; Mitsutaka Syoji; Syuhei Tonomura; Ikuo Yoshida; Toshihiko Masui; Kazuki Inaba; Masahiro Ochiai
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

4.  "Tornado Roux-en-Y" anastomosis in laparoscopy-assisted distal gastrectomy.

Authors:  Eiichiro Toyama; Shinobu Honda; Yoshifumi Baba; Shinji Ishikawa; Naoko Hayashi; Nobutomo Miyanari; Hideo Baba
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

5.  The surgical treatment of chronic gastric atony following Roux-Y diversion for alkaline reflux gastritis.

Authors:  S B Vogel; E R Woodward
Journal:  Ann Surg       Date:  1989-06       Impact factor: 12.969

6.  Minimally Invasive Surgical Approach for the Treatment of Superior Mesenteric Artery Syndrome: Long-Term Outcomes.

Authors:  Javier A Cienfuegos; Luis Hurtado-Pardo; Víctor Valentí; Manuel F Landecho; Isabel Vivas; Mateo G Estévez; Alberto Diez-Caballero; José Luis Hernández-Lizoáin; Fernando Rotellar
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

7.  Clinical and radionuclide evaluation of bile diversion by Braun enteroenterostomy: prevention and treatment of alkaline reflux gastritis. An alternative to Roux-en-Y diversion.

Authors:  S B Vogel; W E Drane; E R Woodward
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

8.  Gastroparesis in pregnancy: case report and literature review.

Authors:  N Achong; N Fagermo; K Scott; M D'emden
Journal:  Obstet Med       Date:  2011-03-01

9.  Completion gastrectomy for refractory gastroparesis following surgery for peptic ulcer disease. Long-term follow-up with subjective and objective parameters.

Authors:  R W McCallum; S C Polepalle; B Schirmer
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

10.  Long-term outcome of completion gastrectomy for nonmalignant disease.

Authors:  M Farahmand; B C Sheppard; C W Deveney; K E Deveney; R A Crass
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.